We think the strategy to find more effective combination therapies in hematology and build a larger oncology and dermatology portfolio is solid, although we're waiting for key data before assuming the ...

A federal judge sided with Doctors for America and ordered the Health and Human Services Department and two other health ...

Fraud, Arrogance, and Tragedy in the Quest to Cure Alzheimer’s,” Charles Piller looks how the amyloid hypothesis took over ...

"AI is going to help kick in some of that load that the scientists and researchers do at the front end to quickly get a diagnosis," said Deema Tarazi.

Vertex Pharmaceuticals forecast annual revenue largely above Wall Street estimates on Monday, banking on robust sales of its ...

The country’s health care system could be in for major changes under the Trump administration. And that could mean a ...

MONDAY, Feb. 10, 2025 (HealthDay News) -- Surgeons at Massachusetts General Hospital have successfully performed the fourth ...

We now have a glimpse behind the curtain of how Medicare arrives at so-called maximum fair prices of prescription drugs it ...

Bristol-Myers Squibb's Cobenfy launch shows strong initial sales and growth potential. Learn why BMY stock is a solid ...

Trump could either weaken the negotiations in a way that benefits the pharmaceutical industry, or try to achieve even deeper savings to outdo his predecessor.

Providers are sympathetic to Medicare enrollees’ concerns but don’t agree on their role in helping patients find less costly ...

Senators must vote against RFK Jr.’s confirmation to protect science, safeguard public health and ensure a committment ...